MCH blood test: what mean corpuscular hemoglobin measures, normal levels, and what high or low MCH means

MCH is calculated by dividing the hemoglobin concentration of your blood by the number of red cells in it, which gives the average hemoglobin mass per cell in picograms, a trillionth of a gram. A bigger cell holds more hemoglobin, so MCH rises and falls with MCV in nearly every condition; what MCH adds is a direct statement about hemoglobin content rather than volume.

Its sibling, MCHC, divides hemoglobin by the hematocrit instead and reports concentration rather than mass. The two answer slightly different questions: MCH asks how much pigment each cell carries, MCHC asks how densely it is packed. In iron deficiency both fall; in a macrocytic anemia MCH rises while MCHC stays normal because the large cells are filled proportionally.

Like the other indices, MCH is an average across millions of cells and is only as reliable as the hemoglobin and red cell count it is derived from. Very high white cell counts, clumped red cells and hemolyzed samples can distort it, so a surprising value is checked on a fresh draw before it is interpreted.

MCH is never ordered alone; it is part of every complete blood count. It becomes useful when the hemoglobin or hematocrit is low and the cause is being sorted out, when MCV is borderline and a second index helps decide whether cells are truly small or large, and when a previous CBC is being compared with a current one to see whether an anemia is responding to treatment.

People in whom MCH is worth a look include those with heavy periods, frequent blood donors, pregnant women, people with gastrointestinal conditions that impair iron or B12 absorption, heavy drinkers, and anyone with a family history of thalassemia. In practice the interpretation follows MCV, and a clinician who has read the MCV rarely learns something new from MCH; its value is confirmatory.

MCH comes with the complete blood count, which can be ordered by your doctor or online through TestWell for a draw at a Quest or Labcorp patient service center. A licensed physician reviews the order; results with reference ranges post to your portal within one to three business days. If anemia is the question, ferritin, an iron panel and vitamin B12 with folate in the same order avoid a return trip.

No fasting is needed. Recent iron therapy, a recent transfusion, heavy alcohol use and a recent illness all shift the indices and should be mentioned. Because MCH is a per-cell average, it changes only as new cells replace old ones, so it lags any change in your iron or vitamin status by weeks and normalizes over about three months after a deficiency is corrected.

Most laboratories report a normal adult MCH of about 27 to 33 picograms; some extend to 26 or 34, and your report's range applies. Men and women share the same range, and it changes little with age after childhood.

Read MCH with MCV. Low MCH with low MCV is the hypochromic, microcytic pattern of iron deficiency and thalassemia; low MCH is expected there and adds little. High MCH with high MCV is the macrocytic pattern of B12 or folate deficiency, alcohol, liver disease, hypothyroidism and certain medications. MCH out of step with MCV is unusual and usually a hint of a mixed picture or an analyzer artifact rather than a distinct disease.

A normal MCH with a low hemoglobin describes normocytic anemia, in which the cells are built normally but there are too few of them: acute blood loss, kidney disease, chronic inflammation, or early deficiency before the indices have had time to change.

A low MCH means each red cell carries less hemoglobin than it should, and in adults it points to iron deficiency first, thalassemia trait second, and less often to anemia of chronic disease, lead exposure or a sideroblastic anemia. The mechanism is the same as for low MCV: without enough usable iron the marrow produces small cells with a light hemoglobin load. Ferritin, ideally with transferrin saturation, is the test that confirms or excludes iron deficiency; when iron studies are normal, hemoglobin electrophoresis looks for thalassemia trait, particularly with the right ancestry, a high red cell count, or a lifelong history of mild microcytosis.

In iron deficiency the pattern reverses slowly with treatment. New cells are larger and carry more hemoglobin, so MCH, MCV and MCHC climb over one to three months, and the RDW is often the first to change because the population is temporarily mixed. Finding and fixing the source of iron loss matters more than the number.

A high MCH nearly always accompanies a high MCV: the cells are large, so each carries more hemoglobin. The causes are those of macrocytosis, in rough order of frequency in adults: alcohol, vitamin B12 deficiency, folate deficiency, medications (methotrexate, hydroxyurea, some antiviral and antiseizure drugs, long-term metformin through B12), liver disease, hypothyroidism, a high reticulocyte count after bleeding or hemolysis, and in older adults a bone marrow disorder. A B12 level with methylmalonic acid, folate, TSH and a liver panel are the usual first tests.

A high MCH with a normal MCV is uncommon and usually reflects an artifact, most often cold agglutinins clumping cells so the analyzer undercounts them, or lipemia interfering with the hemoglobin reading. A repeat sample settles it.

Treat MCH as a pointer to MCV and follow that trail: iron studies and, if normal, hemoglobin electrophoresis for low values; B12 with methylmalonic acid, folate, TSH, liver panel and a medication and alcohol review for high values; a reticulocyte count in either case to see whether the marrow is responding. A recheck of the CBC is informative after six to eight weeks of treatment and definitive at about three months.